» Authors » Agnieszka Smolinska

Agnieszka Smolinska

Explore the profile of Agnieszka Smolinska including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 62
Citations 956
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Arulvasan W, Greenwood J, Ball M, Chou H, Coplowe S, Birch O, et al.
Metabolomics . 2025 Jan; 21(1):17. PMID: 39832034
Introduction: Breath Volatile organic compounds (VOCs) are promising biomarkers for clinical purposes due to their unique properties. Translation of VOC biomarkers into the clinic depends on identification and validation: a...
2.
Cheng H, van Vorstenbosch R, Jonkers D, Masclee A, Schoon E, van Schooten F, et al.
BMJ Open . 2024 Nov; 14(11):e083229. PMID: 39542477
Introduction: Early detection of colorectal cancer (CRC) and clinically relevant (advanced) adenomas leads to a significant reduction of CRC-related mortality and morbidity. However, the faecal immunochemical test (FIT) suffers from...
3.
van Vorstenbosch R, van Munster K, Stavropoulos G, Pachen D, van Schooten F, Ponsioen C, et al.
JHEP Rep . 2024 Aug; 6(8):101103. PMID: 39131082
Background & Aims: Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by progressive inflammation and fibrosis of the bile ducts. PSC is a complex disease of largely...
4.
Smolinska A, Chodkowska M, Kominek A, Janiec J, Piwocka K, Sulejczak D, et al.
Front Cell Dev Biol . 2024 Mar; 12:1227034. PMID: 38455073
High heterogeneity of mesenchymal stem/stromal cells (MSCs) due to different degrees of differentiation of cell subpopulations poses a considerable challenge in preclinical studies. The cells at a pluripotent-like stage represent...
5.
Hintzen K, Blanchet L, Smolinska A, Boumans M, Stobberingh E, Dallinga J, et al.
PLoS One . 2024 Jan; 19(1):e0297086. PMID: 38277384
Introduction: Early and reliable determination of bacterial strain specificity and antibiotic resistance is critical to improve sepsis treatment. Previous research demonstrated the potential of headspace analysis of volatile organic compounds...
6.
van Vorstenbosch R, van Munster K, Pachen D, Mommers A, Stavropoulos G, van Schooten F, et al.
Metabolites . 2024 Jan; 14(1). PMID: 38248826
Up to 5% of inflammatory bowel disease patients may at some point develop primary sclerosing cholangitis (PSC). PSC is a rare liver disease that ultimately results in liver damage, cirrhosis...
7.
van Vorstenbosch R, Mommers A, Pachen D, van Schooten F, Smolinska A
J Breath Res . 2024 Jan; 18(2). PMID: 38237170
Disease detection and monitoring using volatile organic compounds (VOCs) is becoming increasingly popular. For a variety of (gastrointestinal) diseases the microbiome should be considered. As its output is to large...
8.
de Graaf M, Lawton C, Croden F, Smolinska A, Winkens B, Hesselink M, et al.
Lancet Gastroenterol Hepatol . 2023 Dec; 9(2):110-123. PMID: 38040019
Background: Many individuals without coeliac disease or wheat allergy reduce their gluten intake because they believe that gluten causes their gastrointestinal symptoms. Symptoms could be affected by negative expectancy. Therefore,...
9.
Ferrandino G, Ricciardi F, Murgia A, Banda I, Manhota M, Ahmed Y, et al.
Biomedicines . 2023 Nov; 11(11). PMID: 38001958
Cirrhosis detection in primary care relies on low-performing biomarkers. Consequently, up to 75% of subjects with cirrhosis receive their first diagnosis with decompensation when causal treatments are less effective at...
10.
Rouschop S, Smolinska A, Gielen M, De Groot R, Zeegers M, Opperhuizen A, et al.
Front Nutr . 2023 Nov; 10:1264278. PMID: 37927506
The development of inflammatory lung disorders in children may be related to maternal fatty acid intake during pregnancy. We therefore examined maternal fatty acid (FA) status during pregnancy and its...